§3182. Definitions
As used in this Chapter, the following definitions apply:
(1)"Company" means a for-profit sole proprietorship, organization, association,
corporation, partnership, joint venture, limited partnership, limited liability partnership, or
limited liability company, including a wholly owned subsidiary, majority-owned subsidiary,
or parent company of those entities or business associations that exists to make a profit; or
a nonprofit organization.
(2)"Domicile" means any of the following:
(a)The country where a company is registered and headquartered.
(b)The country where a company's affairs are primarily completed.
(c)The country where a majority ownership of the company is held.
(3)"Foreign adversary" means any of the following nations:
(a)The People's Republic of Chin
Free access — add to your briefcase to read the full text and ask questions with AI
§3182. Definitions
As used in this Chapter, the following definitions apply:
(1) "Company" means a for-profit sole proprietorship, organization, association,
corporation, partnership, joint venture, limited partnership, limited liability partnership, or
limited liability company, including a wholly owned subsidiary, majority-owned subsidiary,
or parent company of those entities or business associations that exists to make a profit; or
a nonprofit organization.
(2) "Domicile" means any of the following:
(a) The country where a company is registered and headquartered.
(b) The country where a company's affairs are primarily completed.
(c) The country where a majority ownership of the company is held.
(3) "Foreign adversary" means any of the following nations:
(a) The People's Republic of China including the Hong Kong Special Administrative
Region.
(b) Republic of Cuba.
(c) Islamic Republic of Iran.
(d) Democratic People's Republic of Korea.
(e) Russian Federation.
(4) "Foreign adversary company" means any company, other than a United States
person or United States subsidiary as defined in 15 CFR 772.1, that is any of the following:
(a) Domiciled, incorporated, issued, or listed in a foreign adversary country.
(b) Headquartered in a foreign adversary country.
(c) Has its principal place of business in a foreign adversary country.
(d) Controlled by the government of the People's Republic of China, the Chinese
Communist Party, the Chinese military, or any instrumentality thereof, including the
State-owned Assets Supervision and Administration Commission of the State Council or the
National Social Security Fund.
(e) Is majority-owned by an entity controlled by the government of the People's
Republic of China, the Chinese Communist Party, the Chinese military, or any
instrumentality thereof, including the State-owned Assets Supervision and Administration
Commission of the State Council or the National Social Security Fund.
(f) Itself receives or is the subsidiary of a parent company which receives more than
fifty percent of its total annual revenue from a foreign adversary country.
(5) "Human genetic sequencer" means a device or platform used to conduct human
genetic sequencing, resequencing, isolation, or other genetic research.
(6) "Human genetic sequencing" means any method to determine the identity and
order of nucleotide bases in the human genome.
(7) "Human genome" means the complete set of deoxyribonucleic acid instructions
found within a human cell encompassing all the genetic information needed for an individual
to develop and function.
(8) "Human genomic research facility" means a facility that conducts research on,
with, or relating to genetic sequencing or the human genome.
(9) "Medical facility" means either of the following:
(a) A facility for the delivery of healthcare services that receives state monies
including interagency pass-through appropriations from the federal government.
(b) A facility licensed or certified by this state to provide healthcare services.
(10) "Operational and research software" means a computer program used for the
operation, control, analysis, or other necessary functions of human genetic sequencing or
human genetic sequencers.